{"nctId":"NCT01626859","briefTitle":"A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia","startDateStruct":{"date":"2012-05"},"conditions":["Schizophrenia"],"count":38,"armGroups":[{"label":"MP-214 3mg","type":"EXPERIMENTAL","interventionNames":["Drug: MP-214 3mg"]},{"label":"MP-214 6mg","type":"EXPERIMENTAL","interventionNames":["Drug: MP-214 6mg"]},{"label":"MP-214 9mg","type":"EXPERIMENTAL","interventionNames":["Drug: MP-214 9mg"]}],"interventions":[{"name":"MP-214 3mg","otherNames":[]},{"name":"MP-214 6mg","otherNames":[]},{"name":"MP-214 9mg","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Written informed consent obtained from the patient before the initiation of any study-specific procedures\n* Patients diagnosed with schizophrenia according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for schizophrenia\n* Patients with normal physical examination, laboratory, vital signs, and/or electrocardiogram (ECG)\n\nExclusion Criteria:\n\n* Patients with a DSM-IV-TR diagnosis of schizoaffective disorder, schizophreniform disorder, other psychotic disorders other than schizophrenia, or bipolar I or II disorder\n\nThe information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"64 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Adverse Events as a Measure of Safety and Tolerability","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"15","spread":null},{"groupId":"OG002","value":"11","spread":null}]}]}]},{"type":"PRIMARY","title":"Maximum Plasma Concentration of Unchanged MP-214, M7 (Desmethyl Cariprazine) and M6 (Didesmethyl Cariprazine) at Day 84","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.23","spread":"4.691"},{"groupId":"OG001","value":"22.65","spread":"4.181"},{"groupId":"OG002","value":"28.77","spread":"8.024"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.624","spread":"1.521"},{"groupId":"OG001","value":"5.963","spread":"1.593"},{"groupId":"OG002","value":"8.550","spread":"3.750"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.77","spread":"10.88"},{"groupId":"OG001","value":"35.94","spread":"7.995"},{"groupId":"OG002","value":"51.82","spread":"32.71"}]}]}]},{"type":"PRIMARY","title":"Time to Maximum Plasma Concentration of Unchanged MP-214, M7 (Desmethyl Cariprazine) and M6 (Didesmethyl Cariprazine) at Day 84","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.31","spread":"0.52"},{"groupId":"OG001","value":"3.31","spread":"1.02"},{"groupId":"OG002","value":"3.58","spread":"0.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.45","spread":"1.21"},{"groupId":"OG001","value":"4.77","spread":"2.14"},{"groupId":"OG002","value":"5.60","spread":"1.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.76","spread":"9.21"},{"groupId":"OG001","value":"7.34","spread":"6.83"},{"groupId":"OG002","value":"7.56","spread":"7.27"}]}]}]},{"type":"PRIMARY","title":"Area Under the Plasma Concentration-Time Curve From Time Zero to 24 Hours of Unchanged MP-214, M7 (Desmethyl Cariprazine) and M6 (Didesmethyl Cariprazine) at Day 84","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"155.96","spread":"71.99"},{"groupId":"OG001","value":"358.37","spread":"85.24"},{"groupId":"OG002","value":"466.36","spread":"154.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50.03","spread":"31.19"},{"groupId":"OG001","value":"115.26","spread":"23.47"},{"groupId":"OG002","value":"163.31","spread":"72.72"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"352.03","spread":"252.78"},{"groupId":"OG001","value":"800.21","spread":"206.73"},{"groupId":"OG002","value":"1140.42","spread":"711.59"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":11},"commonTop":["Restlessness","Akathisia","Nasopharyngitis","Insomnia","Schizophrenia"]}}}